Holen Sie sich die Stockscreener-App
26.20
0.61%
-0.16
Handel nachbörslich:
26.38
0.18
+0.69%
Schlusskurs vom Vortag:
$26.36
Offen:
$26.04
24-Stunden-Volumen:
15.41M
Relative Volume:
0.95
Marktkapitalisierung:
$5.72B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$101.26M
KGV:
-154.12
EPS:
-0.17
Netto-Cashflow:
$149.62M
1W Leistung:
-12.72%
1M Leistung:
+20.24%
6M Leistung:
+17.02%
1J Leistung:
+214.15%
1-Tages-Spanne:
$25.31
$27.13
1-Wochen-Bereich:
$24.62
$33.14
52-Wochen-Spanne:
$8.09
$35.02
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
26.20 | 5.72B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
168.06 | 395.79B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
57.16 | 141.37B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
92.03 | 75.19B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
131.32 | 43.79B | 20.10B | 2.61B | 2.90B | 7.71 |
|
KVUE
Kenvue Inc
|
21.77 | 41.74B | 15.46B | 1.06B | 1.40B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Barclays PLC Has $5.68 Million Stake in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Geode Capital Management LLC Increases Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Stock: Growth, Noise, And Where To Focus Now - Barchart
Hims & Hers Stock: Growth, Noise, and Where to Focus Now - MSN
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Sold by Franklin Resources Inc. - MarketBeat
Hims & Hers Health (NYSE:HIMS) Stock Quotes, Forecast and News Summary - Benzinga
Why Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc (MSTR) Plunged Today - MSN
Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It Lasted - Seeking Alpha
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List - Yahoo! Voices
Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls - Yahoo Finance
Hims & Hers Health Are Falling Today: What's Going On? - Benzinga
Hims & Hers Health (NYSE:HIMS) Shares Gap DownHere's Why - MarketBeat
Hims & Hers Stock Skyrockets 200%, Then Is Crashing--What's Next for This Telehealth Powerhouse? - GuruFocus.com
Hims & Hers shares dip amid FDA ruling on compounded medications - The Africa Logistics
Hims & Hers Health falls as FDA issues unfavorable compounded GLP-1 decision - Seeking Alpha
Hims & Hers shares tumble as FDA resolves obesity drug shortage - Investing.com
This Is Huge News for Eli Lilly Investors - The Motley Fool
Hims and Hers Health Stock Testing Key Trendline - Schaeffers Research
Fmr LLC Lowers Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hers Review: Is It Right for You? - Healthline
Morgan Stanley starts Hims & Hers at ‘overweight,’ on strong revenue growth - MSN
Hims & Hers health PAO sells shares worth $336,348 - Investing.com India
Hims & Hers chief commercial officer sells shares worth $822,710 - Investing.com
Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 472 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) CEO Sells $2,314,121.74 in Stock - MarketBeat
Hims & Hers CEO Andrew Dudum sells shares worth $6.24 million - Investing.com
Hims & Hers chief commercial officer sells shares worth $822,710 By Investing.com - Investing.com UK
Hims & Hers Health, Inc. (NYSE:HIMS) Short Interest Up 7.8% in November - MarketBeat
Hims & Hers initiated at overweight by Morgan Stanley on revenue growth - Seeking Alpha
Morgan Stanley Initiates Coverage of Hims & Hers Health (HIMS) with Overweight Recommendation - MSN
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Benzinga
Hims & Hers Health (NYSE:HIMS) Shares Gap UpStill a Buy? - MarketBeat
Morgan Stanley Initiates Bullish Coverage on Hims & Hers Health with 37% Upside - Yahoo Finance
Tesla, crypto miners, Hims & Hers Health: Trending Tickers - Yahoo Finance
Morgan Stanley Initiates Coverage on Hims & Hers Health (NYSE:HIMS) - MarketBeat
Hims & Hers initiated with an Overweight at Morgan Stanley - MSN
Morgan Stanley sets Overweight rating on Hims & Hers stock, cites growth potential - Investing.com
Morgan Stanley bullish on Hims & Hers stock, sees 30% revenue growth ahead - Investing.com India
Morgan Stanley says buy this digital health stock poised to rally more than 50% - CNBC
State Street Corp Raises Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further? - MSN
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health, Inc. (NYSE:HIMS) Given Average Recommendation of "Hold" by Analysts - MarketBeat
4 Stocks That Crushed Analyst Estimates by More Than Double - MSN
Wall Street Sounds Alarm On Hims & Hers Amid Ro-Eli Lilly Zepbound Tie-Up: Retail Shrugs It Off - MSN
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight - Fitt Insider
Hims & Hers: Look At What Matters Most (NYSE:HIMS) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 28,276 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Here’s How Eli Lily (LLY) Caused Hims & Hers (HIMS) Stock To Fall - Yahoo Finance
Hims & Hers Health Unusual Options Activity - Benzinga
Neo Ivy Capital Management Acquires New Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):